Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study ; volume:10 ; number:1 ; day:25 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
Scientific reports ; 10, Heft 1 (25.11.2020), 1-11, 12.2020
- Creator
-
Kawamura, Kentaro
Fukumura, Shinobu
Nikaido, Koki
Tachi, Nobutada
Kozuka, Naoki
Seino, Tsugumi
Hatakeyama, Kingya
Mori, Mitsuru
Ito, Yoichi M.
Takami, Akiyoshi
Hinotsu, Shiro
Kuno, Atsushi
Kawasaki, Yukihiko
Horio, Yoshiyuki
Tsutsumi, Hiroyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-77197-6
- URN
-
urn:nbn:de:101:1-2020123021045680043135
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kawamura, Kentaro
- Fukumura, Shinobu
- Nikaido, Koki
- Tachi, Nobutada
- Kozuka, Naoki
- Seino, Tsugumi
- Hatakeyama, Kingya
- Mori, Mitsuru
- Ito, Yoichi M.
- Takami, Akiyoshi
- Hinotsu, Shiro
- Kuno, Atsushi
- Kawasaki, Yukihiko
- Horio, Yoshiyuki
- Tsutsumi, Hiroyuki
- SpringerLink (Online service)
Other Objects (12)
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial